These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35225565)

  • 21. COVID-19-associated mucormycosis: an epidemic within a pandemic.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2021 Oct; 114(6):355-356. PubMed ID: 34109406
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times.
    Singh AK; Singh R
    Indian J Ophthalmol; 2021 Sep; 69(9):2552. PubMed ID: 34427273
    [No Abstract]   [Full Text] [Related]  

  • 23. Post COVID-19 Mucormycosis - from the Frying Pan into the Fire.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jan; 69(1):13-14. PubMed ID: 34227768
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
    Farias LABG; Damasceno LS; Bandeira SP; Barreto FKA; Leitão TDMJS; Cavalcanti LPG
    Rev Soc Bras Med Trop; 2021; 54():e04102021. PubMed ID: 34495260
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19, DM and Mucormycosis: Prevention is a Mother of Cure.
    Bawaskar HS
    J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436838
    [No Abstract]   [Full Text] [Related]  

  • 26. The surge in Covid related mucormycosis.
    Chandra S; Rawal R
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34126158
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 and orbital mucormycosis.
    Sarkar S; Gokhale T; Choudhury SS; Deb AK
    Indian J Ophthalmol; 2021 Apr; 69(4):1002-1004. PubMed ID: 33727483
    [No Abstract]   [Full Text] [Related]  

  • 28. Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Sep; 69(9):2553. PubMed ID: 34427274
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of mucormycosis in COVID-19 - the need of the hour.
    Ish P; Ish S
    Indian J Ophthalmol; 2021 Jul; 69(7):1969. PubMed ID: 34146076
    [No Abstract]   [Full Text] [Related]  

  • 30. Initial and ongoing challenges with COVID-19-associated mucormycosis.
    Sikka K; Goel G; Sharma N; Thakar A
    Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965
    [No Abstract]   [Full Text] [Related]  

  • 31. Dental surveillance for Post-COVID mucormycosis.
    Balaji SM
    Indian J Dent Res; 2021; 32(1):2. PubMed ID: 34269227
    [No Abstract]   [Full Text] [Related]  

  • 32. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Arora S; Hemmige VS; Mandke C; Chansoria M; Rawat SK; Dravid A; Sethi Y; Medikeri G; Jariwala SP; Puius YA;
    Emerg Infect Dis; 2021; 27(11):2963-2965. PubMed ID: 34586056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal infarction due to COVID-19-associated renal mucormycosis.
    Kurien AA; Srinivasaprasad ND; Valavan KT
    Kidney Int; 2022 Mar; 101(3):655. PubMed ID: 35190047
    [No Abstract]   [Full Text] [Related]  

  • 34. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
    Soman R; Sunavala A
    J Assoc Physicians India; 2021 Jul; 69(7):11-12. PubMed ID: 34431262
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19, steroids, and mucormycosis: What an ophthalmologist should know.
    Tandon A; Pandey L
    Indian J Ophthalmol; 2021 Jul; 69(7):1970. PubMed ID: 34146077
    [No Abstract]   [Full Text] [Related]  

  • 37. Mucormycosis-A serious threat in the COVID-19 pandemic?
    Szarpak L; Chirico F; Pruc M; Szarpak L; Dzieciatkowski T; Rafique Z
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34029629
    [No Abstract]   [Full Text] [Related]  

  • 38. The "black fungus" through a gray lens: Imaging COVID-19-associated mucormycosis.
    Nagesh CP
    Indian J Ophthalmol; 2021 Jul; 69(7):1648-1649. PubMed ID: 34146001
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.